Algo version: 0.98b
Sofiva Genomics CoLtd is listed at the TWO Exchange
Sofiva Genomics CoLtd [6615.TWO]
TWO Sector: Industry:

Is Sofiva Genomics CoLtd stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Sofiva Genomics CoLtd pays dividends. Last time was Friday 26th of July 2024 where the investors holding the stock on Wednesday 3rd of July 2024 were paid TWD0.19898 per share. Over the last 8 times between 2017 and 2024, Sofiva Genomics CoLtd has paid TWD13.19898 with an average of TWD1.65 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Sofiva Genomics CoLtd 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was TWD80.50, you would have made a loss of TWD-38.85 per share or -48.26%

Yes, the average daily trading liquidity for Sofiva Genomics CoLtd is TWD52 800 thousand. You should therefore be able to get in and out of your positions relatively fast.

Sofiva Genomics CoLtd has no real debt, which is good in periods of high inflation. The company has a very low net profit margin of 4.54%, which is challenging.

We have calculated the inflation risk for Sofiva Genomics CoLtd to be low [0.5 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.